Assembly Bio ASMB Stock Research Q4 2025 Better Than Expected RLMD Relmada Therapeutics sinks 55 on 103 EPS miss cash runway concerns intensify for biotech firm What X3 XTKG is doing that smarter investors notice Q4 2019 EPS Misses Views The one metric that defines Alliance Ent AENT success Momentum Fading 20260508